Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158.Kadish A, Quigg R, Schaechter A et al. Defibrillators in nonischemic cardiomyopathy treatment evaluation. Pacing Clin Electrophysiol 2000;23:338-43....
Editor's Note The preliminary results of the first 56 deaths in the Defibrillators in Non-ischemic Cardiomyopathy Treatment Evaluation(DEFINITE)[1]trial were first presented at the American Heart Association 2003 Annual Scientific Sessions held in Orlando, Florida. However, because the mortality rate ...
Non-ischemic cardiomyopathy refers to diseases of the heart that are not the result of reduced blood flow but rather caused by other factors such as viral infections. Learn about the definition, symptoms, and causes of non-ischemic cardiomyopathy. Non-Ischemic Cardiomyopathy Frank is a 54-year-...
Kadish A, Dyer A, Daubert JP, et al for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in patients with left ventricular systolic dysfunction: 14 years after MADIT ...
Methods The effect of statin use on time to death or resuscitated cardiac arrest and time to arrhythmic sudden death was evaluated in 458 patients enrolled in the DEFINITE (DEFIbrillators in Non-Ischemic cardiomyopathy Treatment Evaluation) study. The effect of statin use on time to first ...
Michael Gratch founded Flow Therapy (previously known as Legacy Heart Care) in 2003, in response to a recognized need for broader availability of a non-invasive treatment to the chronic ischemic population. Through his guidance and leadership, Flow Therapy has grown to be the nation’s largest ...
In the DEFINITE (Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation) study (8), in which 458 patients with NICM were randomized to medical therapy or a single-chamber ICD, ICD therapy did not reduce total mortality, despite a significant reduction in SCD. A subgroup analysis of ...
ISCHEMIC CARDIOMYOPATHYINTRACORONARYINFUSIONRecent trends indicate that patients with non-ischemic dilated cardiomyopathy represent the largest subpopulation of heart failure patients with a significant need for alternative treatment modalities. Similar to ischemic cardiomyopathy, patients with non-ischemic dilated ...
after initiation of beta-adrenergic blockers andangiotensin converting enzyme inhibitors, many patients with chemotherapy-induced cardiomyopathy will have normalization ofLVEF[6]. Small trials have also shown that treatment with these agents during chemotherapy may prevent the development of cardiot...
10 March 2017 Non-response on Non-ischemic Cardiomyopathy Ziqing Yu1,2,*, Xueying Chen1,2,*, Fei Han1,2, Shengmei Qin1, Minghui Li1,Yuan Wu1, Yangang Su1 & Junbo Ge1 Cardiac resynchronization therapy (CRT) threw lights on heart failure treatment, however, parts of...